Literature DB >> 1319615

Absence of transplacental passage of fragmin (Kabi) during the second and the third trimesters of pregnancy.

F Forestier, Y Solé, M Aiach, M Alhenc Gélas, F Daffos.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1319615

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  5 in total

Review 1.  Low molecular weight heparins: a guide to their optimum use in pregnancy.

Authors:  Pierre Laurent; Guy-Vincent Dussarat; Jacques Bonal; Christophe Jego; Philippe Talard; Christian Bouchiat; Gilles Cellarier
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Excretion of low molecular weight heparin in human milk.

Authors:  C Richter; J Sitzmann; P Lang; H Weitzel; A Huch; R Huch
Journal:  Br J Clin Pharmacol       Date:  2001-12       Impact factor: 4.335

Review 3.  Pharmacokinetic optimisation of the treatment of deep vein thrombosis.

Authors:  A Iorio; G Agnelli
Journal:  Clin Pharmacokinet       Date:  1997-02       Impact factor: 6.447

Review 4.  Dalteparin sodium. A review of its pharmacology and clinical use in the prevention and treatment of thromboembolic disorders.

Authors:  C J Dunn; E M Sorkin
Journal:  Drugs       Date:  1996-08       Impact factor: 9.546

Review 5.  Models for placental transfer studies of drugs.

Authors:  P Bourget; C Roulot; H Fernandez
Journal:  Clin Pharmacokinet       Date:  1995-02       Impact factor: 6.447
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.